Evidence map›Paper›PMID 11588176›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2001

The neuronal form of adaptor protein-3 is required for synaptic vesicle formation from endosomes.

J Blumstein, V Faundez, F Nakatsu, T Saito, H Ohno, R B Kelly

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 97 citations in OpenAlex.

  1. Biogenesis and reformation of synaptic vesicles.The Journal of physiology · 2025
    Review
  2. Article
  3. Article
  4. Adaptor protein-3 produces synaptic vesicles that release phasic dopamine.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  5. The effect ofFrontiers in immunology · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

J BlumsteinDepartment of Biochemistry and Biophysics, University of California, San Francisco, California 94143-0448, USA.
V Faundez
F Nakatsu
T Saito
H Ohno
R B Kelly
Chiba University · JPUniversity of California, San Francisco · USEmory University · USKanazawa University · JP

Funding

The Presynaptic Vesicle Cycle for the Slow Acting Neurotransmitter SecretionP01DA010154 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KREITZER, ANATOL, SULZER, DAVID · 1995 to 2016
$14.7M
BIOCHEMISTRY OF SYNAPTIC TRANSMISSIONR01NS009878 · NINDS · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI KELLY, REGIS B · 1985 to 2001
$574k
NIDA NIH HHS DA10154NIDA NIH HHS P01 DA010154NINDS NIH HHS NS09878
6 · The paper itself

Abstract

Heterotetrameric adaptor complexes vesiculate donor membranes. One of the adaptor protein complexes, AP-3, is present in two forms; one form is expressed in all tissues of the body, whereas the other is restricted to brain. Mice lacking both the ubiquitous and neuronal forms of AP-3 exhibit neurological disorders that are not observed in mice that are mutant only in the ubiquitous form. To begin to understand the role of neuronal AP-3 in neurological disease, we investigated its function in in vitro assays as well as its localization in neural tissue. In the presence of GTPgammaS both ubiquitous and neuronal forms of AP-3 can bind to purified synaptic vesicles. However, only the neuronal form of AP-3 can produce synaptic vesicles from endosomes in vitro. We also identified that the expression of neuronal AP-3 is limited to varicosities of neuronal-like processes and is expressed in most axons of the brain. Although the AP-2/clathrin pathway is the major route of vesicle production and the relatively minor neuronal AP-3 pathway is not necessary for viability, the absence of the latter could lead to the neurological abnormalities seen in mice lacking the expression of AP-3 in brain. In this study we have identified the first brain-specific function for a neuronal adaptor complex.

Indexed as

Monomeric Clathrin Assembly ProteinsAdaptor Proteins, Vesicular TransportAdenosine TriphosphateAnimalsAntibodiesAxonsBrainBrain ChemistryCarrier ProteinsCell-Free SystemCell LineCytosolEndosomesFemaleGuanosine 5'-O-(3-Thiotriphosphate)HumansAdaptor Proteins, Vesicular TransportAdenosine TriphosphateAntibodiesCarrier Proteinsclathrin assembly protein AP180Guanosine 5'-O-(3-Thiotriphosphate)Membrane ProteinsMonomeric Clathrin Assembly ProteinsProtein IsoformsR-SNARE Proteins

Identifiers

PMID11588176
PMCPMC6763874
OpenAlexW2163046615

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.